Browse by category

Tetra Pharm Technologies advances CB1 antagonist, TPT0701, for appetite suppression

Tetra Pharm Technologies has reached a significant in developing its compound for appetite suppression, TPT0701, following the successful...

SURMOUNT-5: Zepbound superior to Wegovy in head-to-head trial showing an average weight loss of 20.2% vs. 13.7%

1 day ago

LUCIDITY trial to assess Avexitide in post-bariatric hypoglycaemia patients

1 day ago

Inflatable gastric balloon with controller could help people lose weight

1 day ago

Weekly Digest